In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Genius Sports Limited (NYSE: GENI) closed at $9.74 down -3.56% from its previous closing price of $10.1. In other words, the price has decreased by -$3.56 from its previous closing price. On the day, 5.57 million shares were traded. GENI stock price reached its highest trading level at $10.195 during the session, while it also had its lowest trading level at $9.65.
Ratios:
For a deeper understanding of Genius Sports Limited’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.51 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 64.76. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 2.32. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on July 01, 2025, initiated with a Buy rating and assigned the stock a target price of $14.
On April 22, 2025, BTIG Research reiterated its Buy rating and also lowered its target price recommendation from $11 to $12.
On April 21, 2025, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $12.Deutsche Bank initiated its Buy rating on April 21, 2025, with a $12 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 13 ’25 when Burns Daniel Paul bought 8,157 shares for $10.45 per share.
Stevens Eric bought 79,373 shares of GENI for $744,519 on Mar 06 ’25. On Jan 17 ’25, another insider, Davison Jack, who serves as the Officer of the company, bought 100,388 shares for $8.74 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 2307172096 and an Enterprise Value of 2252779520. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.63 while its Price-to-Book (P/B) ratio in mrq is 3.59. Its current Enterprise Value per Revenue stands at 4.209 whereas that against EBITDA is -77.578.
Stock Price History:
The Beta on a monthly basis for GENI is 1.87, which has changed by 0.80036974 over the last 52 weeks, in comparison to a change of 0.1185931 over the same period for the S&P500. Over the past 52 weeks, GENI has reached a high of $11.40, while it has fallen to a 52-week low of $5.29. The 50-Day Moving Average of the stock is -3.43%, while the 200-Day Moving Average is calculated to be 6.73%.
Shares Statistics:
For the past three months, GENI has traded an average of 4.67M shares per day and 7402330 over the past ten days. A total of 239.82M shares are outstanding, with a floating share count of 215.34M. Insiders hold about 10.20% of the company’s shares, while institutions hold 86.41% stake in the company. Shares short for GENI as of 1749772800 were 16392491 with a Short Ratio of 3.51, compared to 1747267200 on 19140975. Therefore, it implies a Short% of Shares Outstanding of 16392491 and a Short% of Float of 7.580000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
